MagGenix is developing a magnetogenetic cell therapy platform that enables the electromagnetic activation of engineered cells within clinical, industrial, and research settings. From a healthcare perspective, our technology allows for localized therapeutic activation with adjustable intensity. MagGenix-enabled CAR-T cells may replicate and function exclusively at tumor sites, while engineered regulatory T cells can secrete anti-inflammatory antibodies only at inflamed locations (e.g., arthritic joints). In doing so, we allow for localized immunostimulation/immunosuppression without disrupting the entirety of the body’s immune system, all through non-invasive electromagnetic stimulation. Within bioproduction, our system allows for cellular activation and modulation in batch or chemostatic bioreactors. It grants the ability to modulate, change, and halt synthesis in large-scale bioreactors with ultra-cost-efficient magnetic stimulation. Within research, the MagGenix-platform can solidify magnetogenetics as the clear successor of opto-/chemo- genetic processes to perturb and study biological systems. MagGenix looks to pioneer its magnetogenetic cell therapy platform for patients, pipettes, and production.
Website: https://maggenix.wordpress.com/
Crunchbase: https://www.crunchbase.com/organization/maggenix
AngelList: https://stack.angellist.com/company/maggenix
Company Details
- Employees
- 4
- Founded
- -
- Address
- Baltimore, Md 21218, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://maggenix.bio/
- HQ
- Baltimore, MD
Maggenix Questions
Maggenix's website is https://maggenix.bio/
Maggenix's LinkedIn profile is https://www.linkedin.com/company/maggenix
Maggenix has
4 employees.
View email and phone details for 4
employees at Maggenix.
Maggenix's industry is
Biotechnology Research
Maggenix's top competitors are
I.e. Advising, Llc,
Chevy Chase Biopartners, Llc,
Bioflare, Inc.,
Equipad,
Nucleate,
Cellicure, Inc.,
Chariot Biosciences,
Sunascen Therapeutics Llc,
Reverra Therapeutics,
Immune3d.
Maggenix's categories are Biotechnology Research
Maggenix's founding year is 2021
